South Africa’s Health Department Faces Challenges with Medicine Supply
The South African Department of Health has revealed that it has been relying on 'Section 21' medicines for the past ten years. These are medications that are legally authorized for use but are not officially registered or licensed within the country. This practice has become a standard procedure for the department when standard treatments are unavailable.
Section 21 medicines are typically used as a 'last resort' to ensure that patients continue to receive necessary care. By allowing the use of these unregistered products, the government aims to prevent gaps in medical treatment. However, the reliance on these alternatives highlights ongoing difficulties in maintaining a consistent supply of standard, registered medication across the national health system.
Health officials have explained that this strategy is essential for managing shortages that occur from time to time. While these medicines undergo a legal review process before being approved for specific patients, they are not part of the regular pharmaceutical supply chain. This means the department must manage special requests and approvals on a case-by-case basis.
As the country continues to navigate medicine shortages, the use of Section 21 products remains a critical tool for public hospitals and clinics. The Department of Health continues to monitor these supplies to ensure that patients receive safe and effective treatment despite the challenges in the global and local medicine market.